Memorial Sloan Kettering Cancer Center New York - Main Campus

New York, New York 10065

1 studies enrolling now · 4 studies all time

What they study most

Biochemically Recurrent Prostate Cancer, MTAP-deleted Solid Tumors, Solid Tumors Harboring NTRK Fusion

Studies at this site

• A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors — Recruiting now
• A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors — Completed
• A Study Called ARAMON to Learn to What Extent Does Study Treatment With Darolutamide Affects Testosterone Levels in Men With Prostate Cancer That Had Not Been Treated With Hormonal Therapy Compared to Treatment With Enzalutamide — Completed
• A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children — Running, not enrolling